Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study

Journal of Headache and Pain

Volumn 17, Issue 1, 2016, Pages

  Find, Ninett Louise ^a,b   Terlizzi, Rossana ^b,c   Munksgaard, Signe Bruun ^b   Bendtsen, Lars ^b   Tassorelli, Cristina ^d   Nappi, Giuseppe ^d   Katsarava, Zaza ^e   Lainez, Miguel ^f   Goicochea, Maria Teresa ^g   Shand, Beatriz ^h   Fadic, Ricardo ^h   Spadafora, Santiago ⁱ   Pagani, Marco ^j   Jensen, Rigmor ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f HOSPITAL CLÍNIC   (Spain)

^g FLENI   (Argentina)

^h PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

ⁱ Universidad ISALUD   (Argentina)

^j Technical Scientific Committee of CBIM (Medical Informatics and Bioenginering Consortium)   (Italy)

more..

Author keywords

Healthcare utilization; International variation; Medication overuse headache; Overuse of acute medication

Indexed keywords

ANALGESIC AGENT; ERGOTAMINE DERIVATIVE; TRIPTAN DERIVATIVE; TRYPTAMINE DERIVATIVE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG INDUCED HEADACHE; EUROPE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OBSERVATIONAL STUDY; ONSET AGE; PATIENT REFERRAL; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; STRUCTURED INTERVIEW; TENSION HEADACHE; CHEMICALLY INDUCED; DRUG MISUSE; MIDDLE AGED; SECONDARY HEADACHE;

ADULT; ANALGESICS; CROSS-SECTIONAL STUDIES; ERGOTAMINES; EUROPE; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PRESCRIPTION DRUG OVERUSE; TRYPTAMINES;

EID: 84960884875     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1186/s10194-016-0612-2     Document Type: Article

References (26)

1. Westergaard ML, Glümer C, Hansen EH, Jensen RH (2014) Prevalence of chronic headache with and without medication overuse: Associations with socioeconomic position and physical and mental health status. Pain 155(10):2005–13
2. Lantéri-Minet M, Auray J-P, El Hasnaoui A et al (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143–9
3. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J et al (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62(8):1338–42
4. Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401
5. Linde M, Gustavsson A (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703–e43
6. Scher AI, Lipton RB, Stewart WF, Bigal M (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30:321–8
7. Kristoffersen ES, Grande RB, Aaseth K et al (2012) Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain 13(2):113–20
8. Maizels M (2002) Health Resource Utilization of the Emergency Department Headache “Repeater.”. Headache 42:747–753
9. Bigal ME, Lipton RB (2009) Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 13:301–7
10. Jonsson P, Linde M, Hensing G, Hedenrud T (2012) Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 13:281–90
11. Allena M, Katsarava Z, Nappi G (2009) From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain 10:71–76
12. Shand B, Goicochea MT, Valenzuela R et al (2015) Clinical and demographical characteristics of patients with medication overuse headache in Argentina and Chile: analysis of the Latin American Section of COMOESTAS Project. J Headache Pain 16:83
13. Tassorelli C, Jensen R, Allena M (2014) A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 34:645–655
14. Bendtsen L, Munksgaard S, Tassorelli C et al (2013) Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 0:1–8
15. Olesen J, Bousser M-G, Diener H-C et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–6. doi:10.1111/j.1468-2982.2006.01172.x
16. Road C (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 26:742–6
17. Munksgaard SB, Bendtsen L, Jensen RH (2012) Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia 32:834–44
18. Hagen K, Albretsen C, Vilming ST et al (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29:221–232
19. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R (2005) Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 20:243–9
20. Sandrini G, Friberg L, Coppola G et al (2011) Neurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition). Eur J Neurol 18:373–81
21. Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: a review. J Pain Res 7:367–78
22. Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011–4
23. Meskunas CA, Tepper SJ, Rapoport AM et al (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46:766–72
24. Dong Z, Chen X, Steiner TJ et al (2014) Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria. Cephalalgia. doi:10.1177/0333102414552533
25. Imai N, Kitamura E, Konishi T et al (2007) Clinical features of probable medication-overuse headache: a retrospective study in Japan. Cephalalgia 27:1020–3
26. Ravishankar K (2008) Medication overuse headache in India. Cephalalgia 28:1223–6